Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1996 Nov;149(5):1639–1650.

Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease.

C Henke 1, P Bitterman 1, U Roongta 1, D Ingbar 1, V Polunovsky 1
PMCID: PMC1865279  PMID: 8909253

Abstract

Fibroblast migration and proliferation within the alveolar wall and airspace after lung injury can lead to the development of fibrosis. Fibroblast cell surface CD44 is an adhesion receptor for provisional matrix proteins and mediates fibroblast invasion into fibrin matrices. Here we show that incubation of cultured fibroblasts with an anti-CD44 monoclonal antibody induces fibroblast detachment from the substratum and morphological changes compatible with apoptosis. In addition, we show that anti-CD44 monoclonal antibody rapidly induces fibroblast apoptosis within fibrin matrices. The effect of anti-CD44 antibody on induction of fibroblast apoptosis occurred within 8 hours and was dose dependent. Anti-CD44 antibody also induced fibroblast apoptosis in suspension. Furthermore, fibroblasts plated on anti-CD44-antibody-coated surfaces initially attached and spread on the antibody; however, after an 8-hour incubation time, many of the cells developed characteristic morphological features of apoptosis. Collectively, these data indicate that apoptosis did not result solely due to detachment from the substratum. Our results identify a new function for fibroblast cell surface CD44 related to the control of cell viability. We suggest this function may be important in fibroblast population control and could potentially be exploited in designing anti-fibrotic therapies.

Full text

PDF
1639

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayroldi E., Cannarile L., Migliorati G., Bartoli A., Nicoletti I., Riccardi C. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood. 1995 Oct 1;86(7):2672–2678. [PubMed] [Google Scholar]
  2. Brooks P. C., Montgomery A. M., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994 Dec 30;79(7):1157–1164. doi: 10.1016/0092-8674(94)90007-8. [DOI] [PubMed] [Google Scholar]
  3. Brown L. F., Lanir N., McDonagh J., Tognazzi K., Dvorak A. M., Dvorak H. F. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993 Jan;142(1):273–283. [PMC free article] [PubMed] [Google Scholar]
  4. Chen B., Polunovsky V., White J., Blazar B., Nakhleh R., Jessurun J., Peterson M., Bitterman P. Mesenchymal cells isolated after acute lung injury manifest an enhanced proliferative phenotype. J Clin Invest. 1992 Nov;90(5):1778–1785. doi: 10.1172/JCI116052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denning S. M., Le P. T., Singer K. H., Haynes B. F. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol. 1990 Jan 1;144(1):7–15. [PubMed] [Google Scholar]
  6. Frisch S. M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994 Feb;124(4):619–626. doi: 10.1083/jcb.124.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fukuda Y., Ishizaki M., Masuda Y., Kimura G., Kawanami O., Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol. 1987 Jan;126(1):171–182. [PMC free article] [PubMed] [Google Scholar]
  8. Galandrini R., Albi N., Tripodi G., Zarcone D., Terenzi A., Moretta A., Grossi C. E., Velardi A. Antibodies to CD44 trigger effector functions of human T cell clones. J Immunol. 1993 May 15;150(10):4225–4235. [PubMed] [Google Scholar]
  9. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henke C., Marineili W., Jessurun J., Fox J., Harms D., Peterson M., Chiang L., Doran P. Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol. 1993 Oct;143(4):1189–1199. [PMC free article] [PubMed] [Google Scholar]
  11. Hunninghake G. W., Kalica A. R. Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):915–918. doi: 10.1164/ajrccm.151.3.7881692. [DOI] [PubMed] [Google Scholar]
  12. Kapanci Y., Weibel E. R., Kaplan H. P., Robinson F. R. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies. Lab Invest. 1969 Jan;20(1):101–118. [PubMed] [Google Scholar]
  13. Katzenstein A. L., Myers J. L., Mazur M. T. Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol. 1986 Apr;10(4):256–267. [PubMed] [Google Scholar]
  14. Meduri G. U., Belenchia J. M., Estes R. J., Wunderink R. G., el Torky M., Leeper K. V., Jr Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids. Chest. 1991 Oct;100(4):943–952. doi: 10.1378/chest.100.4.943. [DOI] [PubMed] [Google Scholar]
  15. Meduri G. U., Chinn A. J., Leeper K. V., Wunderink R. G., Tolley E., Winer-Muram H. T., Khare V., Eltorky M. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest. 1994 May;105(5):1516–1527. doi: 10.1378/chest.105.5.1516. [DOI] [PubMed] [Google Scholar]
  16. Meredith J. E., Jr, Fazeli B., Schwartz M. A. The extracellular matrix as a cell survival factor. Mol Biol Cell. 1993 Sep;4(9):953–961. doi: 10.1091/mbc.4.9.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nagata S., Golstein P. The Fas death factor. Science. 1995 Mar 10;267(5203):1449–1456. doi: 10.1126/science.7533326. [DOI] [PubMed] [Google Scholar]
  18. Noble P. W., Lake F. R., Henson P. M., Riches D. W. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages. J Clin Invest. 1993 Jun;91(6):2368–2377. doi: 10.1172/JCI116469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Polunovsky V. A., Chen B., Henke C., Snover D., Wendt C., Ingbar D. H., Bitterman P. B. Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest. 1993 Jul;92(1):388–397. doi: 10.1172/JCI116578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Polunovsky V. A., Wendt C. H., Ingbar D. H., Peterson M. S., Bitterman P. B. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res. 1994 Oct;214(2):584–594. doi: 10.1006/excr.1994.1296. [DOI] [PubMed] [Google Scholar]
  21. Sconocchia G., Titus J. A., Segal D. M. CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells. J Immunol. 1994 Dec 15;153(12):5473–5481. [PubMed] [Google Scholar]
  22. Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994 Mar 25;76(6):959–962. doi: 10.1016/0092-8674(94)90372-7. [DOI] [PubMed] [Google Scholar]
  23. Suchyta M. R., Elliott C. G., Colby T., Rasmusson B. Y., Morris A. H., Jensen R. L. Open lung biopsy does not correlate with pulmonary function after the adult respiratory distress syndrome. Chest. 1991 May;99(5):1232–1237. doi: 10.1378/chest.99.5.1232. [DOI] [PubMed] [Google Scholar]
  24. Webb D. S., Shimizu Y., Van Seventer G. A., Shaw S., Gerrard T. L. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science. 1990 Sep 14;249(4974):1295–1297. doi: 10.1126/science.1697984. [DOI] [PubMed] [Google Scholar]
  25. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES